A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

Clinical trial NCT02593162 · COMPLETED

Trial details

NCT number: NCT02593162
Sponsor: Trek Therapeutics, PBC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C Viral Infection Chronic Hepatitis C Hepatitis C (HCV)Hepatitis C Genotype 4

Start date: 2015-10-01
Primary completion: 2016-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.